SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIZZI, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.489
EU - Europa 2.256
AS - Asia 1.861
SA - Sud America 140
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 12.757
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.438
SG - Singapore 742
CN - Cina 733
DE - Germania 666
UA - Ucraina 505
TR - Turchia 305
IT - Italia 299
GB - Regno Unito 273
FI - Finlandia 256
BR - Brasile 126
SE - Svezia 92
CA - Canada 45
BE - Belgio 38
RU - Federazione Russa 36
HK - Hong Kong 27
FR - Francia 21
NL - Olanda 20
LT - Lituania 14
IN - India 11
CZ - Repubblica Ceca 10
IR - Iran 7
PL - Polonia 7
UZ - Uzbekistan 6
JP - Giappone 5
AE - Emirati Arabi Uniti 4
AR - Argentina 4
BD - Bangladesh 4
GR - Grecia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CL - Cile 3
HR - Croazia 3
IQ - Iraq 3
NO - Norvegia 3
NP - Nepal 3
SA - Arabia Saudita 3
AT - Austria 2
BG - Bulgaria 2
EC - Ecuador 2
ES - Italia 2
ID - Indonesia 2
IL - Israele 2
MX - Messico 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
PY - Paraguay 2
RO - Romania 2
ZA - Sudafrica 2
AU - Australia 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
SV - El Salvador 1
TN - Tunisia 1
VE - Venezuela 1
Totale 12.757
Salva come PNG Salva come JPEG
Città #
Fairfield 1.156
Woodbridge 1.108
Houston 656
Jacksonville 574
Ann Arbor 564
Ashburn 549
Chandler 513
Seattle 435
Wilmington 409
Cambridge 379
Singapore 375
Santa Clara 374
Munich 223
Izmir 185
Nanjing 154
Beijing 144
Helsinki 141
Princeton 113
Milan 108
San Diego 101
Boardman 100
Shanghai 86
New York 78
Ferrara 61
Nanchang 60
Dearborn 54
Los Angeles 53
Shenyang 47
Brussels 37
Hebei 35
Bremen 34
London 27
Hong Kong 26
Auburn Hills 25
Falkenstein 24
Jiaxing 24
Mountain View 24
San Mateo 24
Falls Church 22
Mcallen 22
Norwalk 21
Tianjin 21
Changsha 19
Jinan 17
Montréal 17
Philadelphia 17
Addison 16
Zhengzhou 16
Redwood City 15
Toronto 15
Bologna 14
Kunming 14
Tappahannock 13
Indiana 12
The Dalles 12
Ningbo 10
São Paulo 9
Washington 9
Orange 8
Padova 8
Verona 8
Düsseldorf 7
Frankfurt am Main 7
Guangzhou 7
Lanzhou 7
Ottawa 7
Warsaw 7
Des Moines 6
Rio de Janeiro 6
San Francisco 6
Hounslow 5
Olomouc 5
Redmond 5
Tashkent 5
Ardabil 4
Augusta 4
Belo Horizonte 4
Brno 4
Fuzhou 4
Jyväskylä 4
Monmouth Junction 4
Tokyo 4
Bari 3
Changchun 3
Charlotte 3
Clifton 3
Curitiba 3
Edinburgh 3
Ferrara di Monte Baldo 3
Hangzhou 3
Hefei 3
Joinville 3
Leawood 3
Prescot 3
Taizhou 3
Zagreb 3
Auckland 2
Betim 2
Bondeno 2
Bonn 2
Totale 9.577
Salva come PNG Salva come JPEG
Nome #
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 293
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 229
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 183
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 182
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 180
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 165
A new selective antagonist of the nociceptin receptor 163
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 158
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 158
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 156
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 155
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 154
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 150
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 147
A new ligand for the urotensin II receptor 147
Pharmacological characterization of nociceptin receptor: an in vitro study 146
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 144
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 143
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 143
Ala scan analogues of HOE 140. Synthesis and biological activities 142
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 140
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 138
Effects of vasoactive agents in healthy and diseased human saphenous veins 138
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 135
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 135
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 135
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 132
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 132
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 131
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 130
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 128
Pharmacological characterization of tachykinin tetrabranched derivatives 128
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 126
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 125
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 125
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 124
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 123
Structure-activity study at positions 3 and 4 of human neuropeptide S. 123
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 122
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 122
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 121
B1 and B2 kinin receptors in various species 121
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 120
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 119
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 119
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 119
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 118
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 117
Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: An in vitro study on human, rabbit and pig vascular B2 receptors 117
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A 116
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) 116
Characterization of endothelin receptors in the human umbilical artery and vein 116
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 116
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. 116
Pharmacology of the Kallikrein-Kinin system 115
Anxiolytic-like effect of neuropeptide S in the rat defensive burying. 115
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 114
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 114
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 114
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 114
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin 114
Pharmacological characterisation of novel kinin B2 receptor ligands 113
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 112
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor 110
null 110
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 110
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 108
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 108
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors 108
Structure-activity relationship study on human urotensin II 108
In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol 107
Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys 106
Receptors for kinins in the human isolated umbilical vein 105
null 105
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor 105
Nociceptin/orphanin FQ receptor ligands, 103
Endogenous nociceptin signaling and stress-induced analgesia 100
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study 100
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery 99
Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities 98
Characterization of the human vascular kinin B2 receptor by binding assays. 98
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 98
Pharmacology of nociceptin and its receptor: a novel therapeutic target 96
Pharmacology of [tyr1]nociceptin analogs: receptor binding and bioassay studies 96
Further studies on nociceptin/orphanin FQ related peptides: discovery of a new chemical template with antagonist activity on the OP4 receptor. 94
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 92
Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues 92
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 91
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 90
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 89
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes. 89
In vitro characterization of FR 190997, the first non peptide B2 receptor agonist receptor binding and bioassay in the human umbilical vein 88
null 87
null 84
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad? 83
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes 81
null 79
MEN 11270, a novel selective constrained peptide antagonist with high affinity at the human B-2 kinin receptor 74
Further studies on nociceptin related peptides: discovery of new molecules with antagonist activity on the nociceptin receptor 72
Pharmacological characterization of the nociceptin receptors in the mouse: receptor binding, bioassay and behavioral studies 71
Totale 12.140
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.987
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020206 0 0 0 0 0 0 0 0 0 0 133 73
2020/20211.470 136 152 60 205 75 160 46 178 31 171 188 68
2021/20221.209 45 117 98 81 65 48 64 80 50 104 112 345
2022/20231.252 119 58 58 162 211 169 97 106 162 5 61 44
2023/2024646 73 82 30 16 35 131 24 57 9 12 21 156
2024/20252.108 67 70 209 108 326 315 126 171 418 239 59 0
Totale 12.857